glp 1 antagonist examples GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Overview of GLP-1 Receptor Agonists

2020 global estimate and projected number of adults through 2035 with an overweight BMI [1]. Obesity is a significant independent risk factor contributing to numerous chronic conditions, including diabetes, hypertension, cardiovascular disease, and obstructive sleep apnea syndrome

Features Akkermansia muciniphila, a key component of a balanced gut microbiome

Due to a short plasma half-life of native GLP-1, several synthesized GLP-1 receptor agonists (RAs) were developed for type 2 diabetes mellitus (DM) treatment

Pens, vials, needles, cartridges, and alcohol wipes shown in photos are not included

Treated with clinical dignity

Conclusions This open-label, single-center pilot study suggests that GLP-1-RAs are an effective and safe treatment option for achieving significant weight loss with a favorable effect on headache, leading to reduced acetazolamide dosage in pwIIH